FDA recall Z-1763-2026

Burlington Medical, LLC · Class II · device

Product

Burlington Medical, Demi Half Aprons.

Reason for recall

Potential for attenuation degradation over time, decreasing the lifespan.

Distribution

Worldwide distribution. Nationwide distribution in the US and international distribution to Canada, Australia, Bangladesh, Chile, Hong Kong, India, Mexico, Malaysia, Panama, Singapore, Thailand, Taiwan, Uruguay, and Vietnam.

Key facts

Status
Ongoing
Initiation date
2026-02-11
Report date
2026-04-08
Voluntary/Mandated
Voluntary: Firm initiated
Location
Newport News, VA, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-1763-2026